1. Home
  2. VERA

VERA

Vera Therapeutics Inc.

Logo Vera Therapeutics Inc.

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-19-2024 1:46pm EST

$
-
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.

Founded: 2016 Country:
United States
United States
Employees: N/A City: BRISBANE
Market Cap: 2.5B IPO Year: 2021
Target Price: $32.29 AVG Volume (30 days): 1.4M
Analyst Decision: Strong Buy Number of Analysts: 8
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -2.25 EPS Growth: N/A
52 Week Low/High: $6.05 - $50.78 Next Earning Date: 05-09-2024
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

Share on Social Networks: